Inventor · disambiguated record
Kristi A. Leonard
Also filed as: LEONARD KRISTI · LEONARD KRISTI A · LEONARD KRISTI ANNE
33 granted patents·15 pending applications·265 citations·filing 2002–2021
97Inventor score
Files withJANSSEN PHARMACEUTICA NV24BARBAY J KENT4DIMENSIONAL PHARM INC4JACKSON PAUL FRANCIS3LEONARD KRISTI A3
Top patents by PatentIndex Score
48 records- 0196US9221804B2Secondary alcohol quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 29, 2015·35 cites·23 claims
- 0295US10487083B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 26, 2019·7 cites·12 claims
- 0395US10294226B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 21, 2019·11 cites·14 claims
- 0494US10364246B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 30, 2019·7 cites·9 claims
- 0593US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0693US11059823B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·4 cites·37 claims
- 0793US9290476B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 22, 2016·31 cites·27 claims
- 0892US8030305B2Triazolopyridazines as kinase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 4, 2011·24 cites·18 claims
- 0991US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 1090US10369146B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 6, 2019·5 cites·13 claims
- 1189US8173654B2Triazolopyridazine compoundsLU TIANBAO·Filed 2008·Granted May 8, 2012·21 cites·15 claims
- 1288US9284308B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 15, 2016·6 cites·21 claims
- 1387US9309222B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 12, 2016·13 cites·25 claims
- 1487US7138530B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Nov 21, 2006·29 cites·48 claims
- 1585US9328095B2Heteroaryl linked quinolinyl modulators of RORgammatJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 3, 2016·3 cites·5 claims
- 1684US9403816B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 2, 2016·3 cites·5 claims
- 1783US7109354B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Sep 19, 2006·17 cites·16 claims
- 1879US9624225B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 18, 2017·3 cites·10 claims
- 1979US9303015B2Heteroaryl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·4 cites·24 claims
- 2078US7482376B2Conjugated complement cascade inhibitorsDIMENSIONAL PHARM INC·Filed 2004·Granted Jan 27, 2009·11 cites·11 claims
- 2177US9346782B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 24, 2016·3 cites·6 claims
- 2277US7662824B2Acylhydrazones as kinase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Feb 16, 2010·2 cites·12 claims
- 2376US6855722B2Substituted indoles and their use as integrin antagonistsDIMENSIONAL PHARM INC·Filed 2002·Granted Feb 15, 2005·10 cites·56 claims
- 2475US12202831B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 21, 2025·0 cites·11 claims
- 2565US7241789B2Substituted indoles and their use as integrin antagonistsDIMENSIONAL PHARMACEUTICAL INC·Filed 2004·Granted Jul 10, 2007·5 cites·21 claims
- 2665US7115598B2Substituted 1,4-diazepines and uses thereofORTHO MCNEIL PHARM INC·Filed 2004·Granted Oct 3, 2006·2 cites·62 claims
- 2763US8883473B2Methods of treatment using allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Nov 11, 2014·1 cites·14 claims
- 2858US7868023B2Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditionsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jan 11, 2011·0 cites·17 claims
- 2954US2007219233A1Substituted Indoles and Their Use as Integrin AntagonistsLU TIANBO·Filed 2007·Application pending·0 cites
- 3052US7385066B2Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditionsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 10, 2008·0 cites·12 claims
- 3151US2016136149A1HETEROARYL LINKED QUINOLINYL MODULATORS OF RORytJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3250US8798939B2Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Aug 5, 2014·0 cites·4 claims
- 3350US2010093723A1HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO[2,3 d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 3450US2010093763A1PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 3550US2010093756A1HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBERBAY J KENT·Filed 2009·Application pending·0 cites
- 3649US10201546B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 12, 2019·0 cites·18 claims
- 3749US2010093721A1PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 3849US2006235007A1Substituted 1,4-diazepines and uses thereofLU TIANBAO·Filed 2006·Application pending·0 cites
- 3947US2010093722A1HETEROARYL AND PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 4043US10555941B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Feb 11, 2020·0 cites·16 claims
- 4140US2012302569A1Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2012·Application pending·0 cites
- 4239US2012129843A1Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activationZHANG YAN·Filed 2011·Application pending·0 cites
- 4339US2012129872A1Fused heteroaryl inhibitors of pro-matrix metalloproteinase activationLEONARD KRISTI ANNE·Filed 2011·Application pending·0 cites
- 4439US2012129897A1Bis heteroaryl inhibitors of pro-matrix metalloproteinase activationBARBAY JOSEPH KENT·Filed 2011·Application pending·0 cites
- 4539US2012129842A1Bisthiazole inhibitors of pro-matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2011·Application pending·0 cites
- 4638US8753857B2Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitorLEONARD KRISTI A·Filed 2012·Granted Jun 17, 2014·0 cites·4 claims
- 4738US2012302573A1Methods of inhibiting pro matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2012·Application pending·0 cites
- 4838US2012129811A1Tricyclic inhibitors of pro-matrix metalloproteinase activationWANG AIHUA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristi A. Leonard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →